✦ LIBER ✦

Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial

✍ Scribed by Michel, P; Adenis, A; Fiore, F Di; Boucher, E; Galais, M P; Dahan, L; Mirabel, X; Hamidou, H; Raoul, J L; Jacob, J H

Book ID: 109998930
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 105 KB
Volume: 95
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6603328

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of induction irinotecan-c

Phase II trial of induction irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for unresectable, locally advanced gastric and oesophageal-gastric junction adenocarcinoma

✍ Fernando Rivera; Maica Galán; Josep Tabernero; Andres Cervantes; Mª Eugenia Vega 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 351 KB

Phase 2 trial of induction and concurren

Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer

✍ David H. Ilson; Bruce D. Minsky; Geoffrey Y. Ku; Valerie Rusch; Nabil Rizk; Mani 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 308 KB

Phase 2 trial of preoperative irinotecan

Phase 2 trial of preoperative irinotecan plus cisplatin and conformal radiotherapy, followed by surgery for esophageal cancer

✍ Jennifer J. Knox; Rebecca Wong; Antonio L. Visbal; Anne M. Horgan; Maha Guindi; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB

Etoposide plus cisplatin followed by con

Etoposide plus cisplatin followed by concurrent chemo-radiotherapy and irinotecan plus cisplatin for patients with limited-stage small cell lung cancer: A multicenter phase II study

✍ Xenidis, N.; Kotsakis, A.; Kalykaki, A.; Christophyllakis, Ch.; Giassas, S.; Ken 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Phase II trial of irinotecan and cisplat

Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer

✍ Joo Hyuk Sohn; Yong Wha Moon; Chang Geol Lee; Gwi Eon Kim; Kyung Young Chung; Jo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract ## BACKGROUND. A Phase II trial of irinotecan and cisplatin (IP) with early concurrent radiotherapy was performed in limited‐disease small‐cell lung cancer (LD‐SCLC) to evaluate the efficacy and toxicity. ## METHODS. For untreated LD‐SCLC patients, irinotecan (60 mg/m^2^, Days 1, 8,

P-776 Phase II trial of irinotecan and c

P-776 Phase II trial of irinotecan and cisplatin with concurrent radiotherapy in limited-disease small cell lung cancer

✍ Kim, J.; Moon, Y.; Sohn, J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB